Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 2,617 $ 78,005,004 $ 636,886 $ (48,357,638) $ 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Shares issued upon conversion of KBL debt $ 47 1,941,078 1,941,125
Shares issued upon conversion of KBL debt (in Shares) 467,123        
Shares issued upon conversion of 180 debt $ 16 432,367 432,383
Shares issued upon conversion of 180 debt (in Shares) 158,383        
Shares issued in connection with the financing, net of financing costs [1] $ 256 10,730,814 10,731,070
Shares issued in connection with the financing, net of financing costs (in Shares) [1] 2,564,000        
Offering costs allocated to warrant liabilities [1] 604,118 604,118
Warrants issued in connection with private offering, reclassified to derivative liabilities (7,294,836) (7,294,836)
Shares issued upon exchange of common stock equivalents $ 96 (96)
Shares issued upon exchange of common stock equivalents (in Shares) 959,809        
Common stock $ 20 925,384 925,404
Common stock (in Shares) 197,790        
Stock based compensation,Options 1,092,399 1,092,399
Comprehensive income (loss):          
Net income (loss) (16,198,585) (16,198,585)
Other comprehensive income (loss) 189,348 189,348
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Comprehensive income (loss):          
Net income (loss)         (39,657,721)
Balance at Jun. 30, 2021 $ 3,106 89,495,704 1,232,721 (88,015,359) 2,716,172
Balance (in Shares) at Jun. 30, 2021 31,061,354        
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Common stock $ 4 378,655 378,659
Common stock (in Shares) 37,515        
Stock based compensation,Options 344,095 344,095
Comprehensive income (loss):          
Correction of an error 363,523 363,523
Net income (loss) (23,459,136) (23,459,136)
Other comprehensive income (loss) 406,487 406,487
Balance at Jun. 30, 2021 $ 3,106 89,495,704 1,232,721 (88,015,359) 2,716,172
Balance (in Shares) at Jun. 30, 2021 31,061,354        
Comprehensive income (loss):          
Shares issued to settle accounts payable $ 23 1,973,227 1,973,250
Shares issued to settle accounts payable (in Shares) 225,000        
Impact of transfer agent reconciliation $ 28 (28)
Impact of transfer agent reconciliation (in Shares) 280,509        
Balance at Dec. 31, 2021 $ 3,404 107,184,137 817,440 (68,682,286) 39,322,695
Balance (in Shares) at Dec. 31, 2021 34,035,925        
Comprehensive income (loss):          
Shares issued for directors’ and professional fees $ 5 149,713 149,718
Shares issued for directors’ and professional fees (in Shares) 51,319        
Stock based compensation   596,467     596,467
Net income (loss) 1,563,713 1,563,713
Other comprehensive income (loss) (728,081) (728,081)
Balance at Mar. 31, 2022 $ 3,409 107,930,317 89,359 (67,118,573) 40,904,512
Balance (in Shares) at Mar. 31, 2022 34,087,244        
Balance at Dec. 31, 2021 $ 3,404 107,184,137 817,440 (68,682,286) 39,322,695
Balance (in Shares) at Dec. 31, 2021 34,035,925        
Comprehensive income (loss):          
Net income (loss)         4,502,997
Balance at Jun. 30, 2022 $ 3,414 108,785,991 (1,818,692) (64,179,289) 42,791,424
Balance (in Shares) at Jun. 30, 2022 34,143,823        
Balance at Mar. 31, 2022 $ 3,409 107,930,317 89,359 (67,118,573) 40,904,512
Balance (in Shares) at Mar. 31, 2022 34,087,244        
Comprehensive income (loss):          
Shares issued for directors’ and professional fees $ 4 60,623 60,627
Shares issued for directors’ and professional fees (in Shares) 44,579        
Stock based compensation $ 1 795,051     795,052
Stock based compensation (in Shares) 12,000        
Net income (loss) 2,939,284 2,939,284
Other comprehensive income (loss) (1,908,051) (1,908,051)
Balance at Jun. 30, 2022 $ 3,414 $ 108,785,991 $ (1,818,692) $ (64,179,289) $ 42,791,424
Balance (in Shares) at Jun. 30, 2022 34,143,823        
[1] Consists of $11,666,200 of gross proceeds from the February 2021 PIPE offering, net of placement agent fees and other cash offering costs of $968,930. Of the $968,930 of offering costs, $364,812 was allocated to the common stock and $604,118 was allocated to the warrant liabilities and expensed immediately due to their liability classification.